192 related articles for article (PubMed ID: 34287856)
21. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
[TBL] [Abstract][Full Text] [Related]
22. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.
; Steg PG; Jolly SS; Mehta SR; Afzal R; Xavier D; Rupprecht HJ; López-Sendón JL; Budaj A; Diaz R; Avezum A; Widimsky P; Rao SV; Chrolavicius S; Meeks B; Joyner C; Pogue J; Yusuf S
JAMA; 2010 Sep; 304(12):1339-49. PubMed ID: 20805623
[TBL] [Abstract][Full Text] [Related]
23. Factor Xa inactivation in acute coronary syndrome.
Barantke M; Bonnemeier H
Curr Pharm Des; 2008; 14(12):1186-90. PubMed ID: 18473865
[TBL] [Abstract][Full Text] [Related]
24. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome.
Hao Y; Liu J; Liu J; Yang N; Smith SC; Huo Y; Fonarow GC; Ge J; Taubert KA; Morgan L; Zhou M; Xing Y; Ma CS; Han Y; Zhao D
Circulation; 2019 Apr; 139(15):1776-1785. PubMed ID: 30667281
[TBL] [Abstract][Full Text] [Related]
25. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
[TBL] [Abstract][Full Text] [Related]
26. Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registry.
Ge Z; Baber U; Claessen BE; Chandrasekhar J; Chandiramani R; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
J Thromb Thrombolysis; 2019 Jul; 48(1):42-51. PubMed ID: 30924052
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery.
van Diepen S; Tricoci P; Podder M; Westerhout CM; Aylward PE; Held C; Van de Werf F; Strony J; Wallentin L; Moliterno DJ; White HD; Mahaffey KW; Harrington RA; Armstrong PW
J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26672080
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project.
Zhou M; Liu J; Hao Y; Liu J; Huo Y; Smith SC; Ge J; Ma C; Han Y; Fonarow GC; Taubert KA; Morgan L; Yang N; Xing Y; Zhao D;
Cardiovasc Diabetol; 2018 Nov; 17(1):147. PubMed ID: 30482187
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Harrington RA; Becker RC; Cannon CP; Gutterman D; Lincoff AM; Popma JJ; Steg G; Guyatt GH; Goodman SG
Chest; 2008 Jun; 133(6 Suppl):670S-707S. PubMed ID: 18574276
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial.
De Servi S; Goedicke J; Schirmer A; Widimsky P
Eur Heart J Acute Cardiovasc Care; 2014 Dec; 3(4):363-72. PubMed ID: 24818952
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of bivalirudin monotherapy in patients with non-ST-segment elevation acute coronary syndromes with positive biomarkers undergoing percutaneous coronary intervention: a report from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Huang X; Chen S; Redfors B; Zhang Y; Souza CF; Mehran R; Bansilal S; Kirtane AJ; Brener SJ; Feite F; Dangas GD; Ben-Yehuda O; Stone GW
Coron Artery Dis; 2020 Jan; 31(1):59-65. PubMed ID: 31809479
[TBL] [Abstract][Full Text] [Related]
33. Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis.
Chiarito M; Cao D; Cannata F; Godino C; Lodigiani C; Ferrante G; Lopes RD; Alexander JH; Reimers B; Condorelli G; Stefanini GG
JAMA Cardiol; 2018 Mar; 3(3):234-241. PubMed ID: 29417147
[TBL] [Abstract][Full Text] [Related]
34. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
[TBL] [Abstract][Full Text] [Related]
35. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative.
Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT
Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757
[TBL] [Abstract][Full Text] [Related]
36. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes.
Elbarouni B; Elmanfud O; Yan RT; Fox KA; Kornder JM; Rose B; Spencer FA; Welsh RC; Wong GC; Goodman SG; Yan AT
Am Heart J; 2010 Sep; 160(3):420-7. PubMed ID: 20826248
[TBL] [Abstract][Full Text] [Related]
37. Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
Armaganijan LV; Alexander KP; Huang Z; Tricoci P; Held C; Van de Werf F; Armstrong PW; Aylward PE; White HD; Moliterno DJ; Wallentin L; Chen E; Harrington RA; Strony J; Mahaffey KW; Lopes RD
Am Heart J; 2016 Aug; 178():176-84. PubMed ID: 27502866
[TBL] [Abstract][Full Text] [Related]
38. A risk score to predict bleeding in patients with acute coronary syndromes.
Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
[TBL] [Abstract][Full Text] [Related]
39. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
[TBL] [Abstract][Full Text] [Related]
40. Features of Parenteral Anticoagulant Therapy in Patients With Myocardial Infarction According to the Russian Register of Acute Myocardial Infarction - REGION-IM.
Boytsov SA; Shakhnovich RM; Tereschenko SN; Erlikh AD; Pevsner DV; Gulyan RG
Kardiologiia; 2022 Oct; 62(10):3-15. PubMed ID: 36384404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
